Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents.
- Author:
Wen-ying YANG
1
;
Qiu-he JI
;
Da-long ZHU
;
Jin-kui YANG
;
Lu-lu CHEN
;
Zhi-min LIU
;
De-min YU
;
Li YAN
Author Information
1. Department of Endocrinology, China-Japan Friendship Hospital, Beijing, China. yangwenying1707@yahoo.com.cn
- Publication Type:Journal Article
- MeSH:
Biphasic Insulins;
Diabetes Mellitus, Type 2;
drug therapy;
Female;
Humans;
Hypoglycemic Agents;
administration & dosage;
Insulin;
administration & dosage;
analogs & derivatives;
Insulin Aspart;
Insulin, Isophane;
Male;
Middle Aged;
Treatment Outcome
- From:
Chinese Medical Journal
2009;122(14):1704-1708
- CountryChina
- Language:English
